Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Aims To Steer Bar Code Debate Toward Alternatives To FDA Proposal

This article was originally published in The Gray Sheet

Executive Summary

Voluntary use of automatic identification technologies should be explored in lieu of an FDA bar code labeling requirement for medical devices, industry reps say

You may also be interested in...



House Debates Medical Error Legislation Versus Self-Regulation

The House Energy & Commerce Committee has yet to decide whether to develop legislation aimed at reducing medical errors or defer to industry self-regulation

FDA Regulatory News In Brief

Device tracking: 1Medical device tracking final rule amending 1993 reg to reflect changes under FDAMA is effective May 9. No revisions are made to the April 25, 2000 proposed rule (2"The Gray Sheet" May 1, 2000, In Brief). The rule "makes no revisions to the regulation's existing system and content tracking requirements, the current obligations of persons other than device manufacturers, such as distributors, records and inspection requirements and existing record retention requirements." A final guidance on medical device tracking was issued Jan. 24, 2000...

Device Bar-Coding Advocated By GPOs; FDA Cost Analysis Awaited

FDA may decide to pursue a medical device bar-code labeling requirement independently of the rulemaking process for drugs and biologics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016896

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel